Trial: 201909144

A Phase 1 Dose Escalation Study To Assess Safety And Efficacy Of ADP-A2M4CD8 In HLA-A2+ Subjects With MAGE-A4 Positive Tumors

Phase

I

Principal Investigator

Van Tine, Brian

Disease Site

Esophagus; Larynx; Lip, Oral Cavity and Pharynx; Lung; Melanoma, Skin; Other Female Genital; Stomach; Urinary Bladder

Learn more about this study at: clinicaltrials.gov